Cadherin switching and bladder cancer

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 423-431

  Bryan, Richard T ^a   Tselepis, Chris ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

cadherins; cell adhesion; cell biology; urinary bladder neoplasms

Indexed keywords

CADHERIN; CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; P CADHERIN; UVOMORULIN;

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GROWTH; CELL ADHESION; CELL SURVIVAL; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EVIDENCE BASED PRACTICE; GENE EXPRESSION; GENE SWITCHING; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; LABORATORY TEST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; UROTHELIUM;

CADHERINS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; URINARY BLADDER NEOPLASMS;

EID: 77955471173     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.04.016     Document Type: Review

References (50)

1. B.W. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 2009 Epub ahead of print
2. M. Ploeg, K.K. Aben, and L.A. Kiemeney The present and future burden of urinary bladder cancer in the world World J Urol 27 2009 289
3. M.J. Horner, L.A.G. Ries, and M. Krapcho SEER Cancer Statistics Review, 19752006 2009 National Cancer Institute Bethesda, Maryland
4. V. Lorusso, and N. Silvestris Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions Ann Oncol 16 suppl. 2005 iv85
5. D.M. Wallace, R.T. Bryan, and J.A. Dunn Delay and survival in bladder cancer BJU Int 89 2002 868
6. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 202
7. S.M. Donat, A. Shabsigh, and C. Savage Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience Eur Urol 55 2009 177
8. A. Shabsigh, R. Korets, and K.C. Vora Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology Eur Urol 55 2009 164
9. U. Cavallaro, B. Schaffhauser, and G. Christofori Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176 2002 123
10. P. Hulpiau, and F. van Roy Molecular evolution of the cadherin superfamily Int J Biochem Cell Biol 41 2009 349
11. A. Jeanes, C.J. Gottardi, and A.S. Yap Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27 2008 6920
12. M.P. Stemmler Cadherins in development and cancer Mol Biosyst 4 2008 835
13. O. De Wevel, P. Pauwels, and B. De Craene Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front Histochem Cell Biol 130 2008 481
14. M.J. Wheelock, Y. Shintani, and M. Maeda Cadherin switching J Cell Sci 121 2008 727
15. M. Yilmaz, and G. Christofori EMT, the cytoskeleton, and cancer cell invasion Cancer Metastasis Rev 28 2009 15
16. R.T. Bryan, P.A. Atherfold, and Y. Yeo Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies J Pathol 215 2008 184
17. R.G. Hardy, C. Tselepis, and J. Hoyland Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon Gut 50 2002 513
18. K.M. Rieger-Christ, J.W. Cain, and J.W. Braasch Expression of classic cadherins type I in urothelial neoplastic progression Hum Pathol 32 2001 18
19. F. Nollet, P. Kools, and F. van Roy Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members J Mol Biol 299 2000 551
20. A. Nose, and M. Takeichi A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos J Cell Biol 103 1986 2649
21. R. Kemler, C. Babinet, and H. Eisen Surface antigen in early differentiation Proc Natl Acad Sci U S A 74 1977 4449
22. G.L. Radice, H. Rayburn, and H. Matsunami Developmental defects in mouse embryos lacking N-cadherin Dev Biol 181 1997 64
23. Y. Shimoyama, S. Hirohashi, and S. Hirano Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas Cancer Res 49 1989 2128
24. G.L. Radice, M.C. Ferreira-Cornwell, and S.D. Robinson Precocious mammary gland development in P-cadherin-deficient mice J Cell Biol 139 1997 1025
25. Y. Shimoyama, T. Yoshida, and M. Terada Molecular cloning of a human Ca2+-dependent cell-cell adhesion molecule homologous to mouse placental cadherin: its low expression in human placental tissues J Cell Biol 109 1989 1787
26. K. Hatta, T.S. Okada, and M. Takeichi A monoclonal antibody disrupting calcium-dependent cell-cell adhesion of brain tissues: possible role of its target antigen in animal pattern formation Proc Natl Acad Sci U S A 82 1985 2789
27. M. Takeichi The cadherins: cell-cell adhesion molecules controlling animal morphogenesis Development 102 1988 639
28. P. Friedl, and D. Gilmour Collective cell migration in morphogenesis, regeneration and cancer Nat Rev Mol Cell Biol 10 2009 445
29. A.C. Chiang, and J. Massague Molecular basis of metastasis N Engl J Med 359 2008 2814
30. C. Tselepis, I. Perry, and J. Jankowski Barrett's esophagus: disregulation of cell cycling and intercellular adhesion in the metaplasia-dysplasia-carcinoma sequence Digestion 61 2000 1
31. M. Maeda, K.R. Johnson, and M.J. Wheelock Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition J Cell Sci 118 2005 873
32. J.A. Mandeville, B. Silva Neto, and A.J. Vanni P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells BJU Int 102 2008 1707
33. A.S. Ribeiro, A. Albergaria, and B. Sousa Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells Oncogene 2009
34. M.T. Nieman, R.S. Prudoff, and K.R. Johnson N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression J Cell Biol 147 1999 631
35. K. Taniuchi, H. Nakagawa, and M. Hosokawa Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases Cancer Res 65 2005 3092
36. K. Gravdal, O.J. Halvorsen, and S.A. Haukaas A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clin Cancer Res 13 2007 7003
37. M. Jaggi, T. Nazemi, and N.A. Abrahams N-cadherin switching occurs in high Gleason grade prostate cancer Prostate 66 2006 193
38. I.S. Patel, P. Madan, and S. Getsios Cadherin switching in ovarian cancer progression Int J Cancer 106 2003 172
39. G. Li, K. Satyamoorthy, and M. Herlyn N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells Cancer Res 61 2001 3819
40. T. Tani, L. Laitinen, and L. Kangas Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts Int J Cancer 64 1995 407
41. M.A. Esteban, M.G. Tran, and S.K. Harten Regulation of E-cadherin expression by VHL and hypoxia-inducible factor Cancer Res 66 2006 3567
42. M.M. Faraldo, J. Teuliere, and M.A. Deugnier Beta-catenin regulates P-cadherin expression in mammary basal epithelial cells FEBS Lett 581 2007 831
43. K. Bauer, A. Dowejko, and A.K. Bosserhoff P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated snail phosphorylation Carcinogenesis 30 2009 1781
44. D.F. Jarrard, R. Paul, and A. van Bokhoven P-cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer Clin Cancer Res 3 1997 2121
45. A. Milicic, L.A. Harrison, and R.A. Goodlad Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo Cancer Res 68 2008 7760
46. P.P. Bringuier, R. Umbas, and H.E. Schaafsma Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors Cancer Res 53 1993 3241
47. I. Lascombe, A. Clairotte, and S. Fauconnet N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors Clin Cancer Res 12 2006 2780
48. E. Baumgart, M.S. Cohen, and B. Silva Neto Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors Clin Cancer Res 13 2007 1685
49. K.M. Rieger-Christ, P. Lee, and R. Zagha Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway Oncogene 23 2004 4745
50. H. Wallerand, Y. Cai, and Z.A. Wainberg Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines Urol Oncol 28 2010 180